Prime Medicine
PRME
PRME
162 hedge funds and large institutions have $512M invested in Prime Medicine in 2025 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 63 increasing their positions, 31 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
42% more call options, than puts
Call options by funds: $8.69M | Put options by funds: $6.12M
35% more funds holding
Funds holding: 120 → 162 (+42)
23.91% more ownership
Funds ownership: 44.71% → 68.62% (+24%)
Holders
162
Holding in Top 10
2
Calls
$8.69M
Puts
$6.12M
Top Buyers
| 1 | +$22.2M | |
| 2 | +$17.5M | |
| 3 | +$16.6M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$16.6M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$15.1M |
Top Sellers
| 1 | -$11M | |
| 2 | -$5.16M | |
| 3 | -$1.44M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.25M |
| 5 |
GWM
Greenwich Wealth Management
Greenwich,
Connecticut
|
-$699K |
